论文部分内容阅读
作者选择由于大脑中动脉近端闭塞所致急性卒中病人19例,应用尿激酶显示有积极的治疗效果。 病例选择符合以下条件:(1)入院时卒中症状稳定至少4h;(2)Orgogozo卒中指标积分<50,且在血管造影前无改善;(3)由患者或家属签字同意;(4)头颅CT无出血,占位效应或腔隙梗塞;(5)血管造影显示颈内动脉(ICA)或大脑中动脉(MCA)主干完全闭塞;(6)症状发生距溶栓治疗6h内。造影前给予胶体扩溶和肝素。尿激酶通过导管末端进入血栓。尿激酶500 IU混合在0.2ml盐水球囊中,以2.5·10~4IU/min速度输入,分别于输入3·10~5、6·10~5、9·10~5IU后造影,总剂量不超过9·10~5IU;再通后
The authors selected 19 patients with acute stroke due to proximal occlusion of the middle cerebral artery and showed a positive therapeutic effect using urokinase. (2) Orgogozo stroke score <50 and no improvement prior to angiography; (3) signature or consent of the patient or family member; (4) cranial CT No hemorrhage, mass effect or lacunar infarction; (5) angiography showed complete occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA); (6) symptoms within 6h from thrombolytic therapy. Preoperative contrast given gel solubilization and heparin. Urokinase enters the thrombus through the end of the catheter. Urokinase 500 IU mixed in 0.2ml saline balloon, 2.5 ~ 10 ~ 4IU / min speed input, respectively, after the importation of 3 · 10 ~ 5,6 · 10 ~ 5,9 · 10 ~ 5IU angiography, the total dose is not More than 9 · 10 ~ 5IU;